NMC Health Plc (LSE:NMC) agreed to acquire 80% stake in Al Salam Medical Group for $37 million on January 22, 2018. The deal value includes an initial payment of $37 million on completion and a deferred consideration to be paid after 1 year based on business's financial performance. The purchase consideration translates into a blended 2018E EV/EBITDA multiple of less than 7x. The transaction is expected to be completed in the first half of 2018 and is expected to be earnings accretive from first year of acquisition. JPMorgan Chase & Co. acted as a financial advisor to NMC Health Plc.